Primary Tumor Volume Is an Important Predictor of Clinical Outcomes Among Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck Treated With Definitive ChemoradiotherapyAnna Strongin, Mohan Suntharalingam, Susannah Yovino et al.|International Journal of Radiation Oncology*Biology*Physics|2011Cited by 116
Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapyCharles E. Rutter, Mohan Suntharalingam, Susannah Yovino et al.|Head & Neck|2010Cited by 88
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)Dan P. Zandberg, Martin J. Edelman, Sandra Rollins et al.|Cancer Immunology Immunotherapy|2014Cited by 75
Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10‐year experience at the University of Maryland Greenebaum Cancer CenterDan P. Zandberg, Kevin J. Cullen, Olga Goloubeva et al.|Head & Neck|2014Cited by 58
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and managementNajeebah A. Bade, Ashkan Emadi, Crystal Lu et al.|Journal of Oncology Pharmacy Practice|2019Cited by 42